Biotechnology
The Biotechnology industry has a total of 604 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.23 billion.
Market Cap
1.12T
Revenue
105.23B
Profits
-42.06B
PE Ratio
n/a
Profit Margin
-39.98%
Dividend Yield
0.04%
604 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.69B | 1.37% | 1,617,713 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.06B | -0.74% | 796,558 | 14.25B |
| 3 | ARGX | argenx SE | 54.11B | -1.30% | 288,778 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 52.52B | -3.65% | 1,659,198 | 3.21B |
| 5 | INSM | Insmed Incorporated | 42.02B | 0.91% | 1,898,027 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 35.31B | -0.55% | 179,667 | 4.97B |
| 7 | BNTX | BioNTech SE | 22.80B | -1.24% | 757,696 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.16B | -1.08% | 6,350,000 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.50B | -3.07% | 1,932,142 | 3.85B |
| 10 | INCY | Incyte Corporation | 18.73B | -0.72% | 2,264,426 | 4.81B |
| 11 | ROIV | Roivant Sciences Ltd. | 15.37B | 3.56% | 12,372,813 | 20.33M |
| 12 | RVMD | Revolution Medicines, Inc. | 15.26B | 0.52% | 2,239,917 | - |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.48B | 1.46% | 1,596,511 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.55B | -2.33% | 1,590,362 | - |
| 15 | ASND | Ascendis Pharma A/S | 13.47B | 4.88% | 1,428,400 | 758.59M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.09B | 2.12% | 1,468,875 | 966.96M |
| 17 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.98B | 0.02% | 177,492 | 740.64M |
| 18 | MRNA | Moderna, Inc. | 11.51B | -0.57% | 12,305,027 | 2.23B |
| 19 | EXEL | Exelixis, Inc. | 11.00B | -1.23% | 2,569,098 | 2.29B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.82B | 0.32% | 1,226,909 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.24B | 0.60% | 1,576,632 | 3.09B |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 10.18B | 1.58% | 606,088 | 4.16B |
| 23 | ABVX | ABIVAX Société Anonyme | 9.60B | -5.67% | 1,609,822 | 7.07M |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.52B | -1.03% | 1,555,161 | 829.45M |
| 25 | CORT | Corcept Therapeutics Incorporated | 9.26B | 0.99% | 1,029,088 | 741.17M |
| 26 | TECH | Bio-Techne Corporation | 9.12B | -2.90% | 2,259,731 | 1.22B |
| 27 | NUVL | Nuvalent, Inc. | 8.13B | -1.12% | 523,938 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 7.75B | 4.25% | 1,621,357 | 87.21M |
| 29 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.58B | -3.45% | 1,743,357 | 174.33M |
| 30 | CAI | Caris Life Sciences, Inc. | 7.55B | 0.83% | 1,785,315 | 649.06M |
| 31 | AXSM | Axsome Therapeutics, Inc. | 7.47B | -0.39% | 554,079 | 561.26M |
| 32 | MRUS | Merus N.V. | 7.35B | 0.31% | 708,196 | 56.61M |
| 33 | HALO | Halozyme Therapeutics, Inc. | 7.32B | 0.50% | 5,628,724 | 1.24B |
| 34 | KYMR | Kymera Therapeutics, Inc. | 7.17B | 2.13% | 1,863,724 | 43.74M |
| 35 | KRYS | Krystal Biotech, Inc. | 7.09B | -0.86% | 333,345 | 373.16M |
| 36 | CDTX | Cidara Therapeutics, Inc. | 6.94B | 0.21% | 551,084 | 302.00K |
| 37 | PRAX | Praxis Precision Medicines, Inc. | 6.72B | 0.57% | 403,000 | 7.46M |
| 38 | COGT | Cogent Biosciences, Inc. | 6.41B | 5.17% | 2,859,216 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 6.07B | 0.27% | 886,795 | 1.78B |
| 40 | PTGX | Protagonist Therapeutics, Inc. | 5.96B | 3.36% | 1,287,129 | 209.22M |
| 41 | PCVX | Vaxcyte, Inc. | 5.83B | -0.20% | 1,658,314 | - |
| 42 | CRSP | CRISPR Therapeutics AG | 5.40B | -2.43% | 1,402,461 | 38.34M |
| 43 | BLTE | Belite Bio, Inc | 5.30B | -5.94% | 169,953 | - |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.20B | 0.72% | 1,153,602 | - |
| 45 | CELC | Celcuity Inc. | 4.87B | 4.45% | 1,242,942 | - |
| 46 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.79B | 2.39% | 1,113,597 | 1.54M |
| 47 | TERN | Terns Pharmaceuticals, Inc. | 4.78B | -4.44% | 6,876,186 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.78B | 0.09% | 1,932,560 | - |
| 49 | ADMA | ADMA Biologics, Inc. | 4.71B | -2.94% | 2,373,848 | 488.56M |
| 50 | IMVT | Immunovant, Inc. | 4.63B | 6.49% | 3,722,811 | - |
| 51 | ACAD | ACADIA Pharmaceuticals Inc. | 4.59B | 1.76% | 1,399,060 | 1.05B |
| 52 | TGTX | TG Therapeutics, Inc. | 4.58B | -2.03% | 1,097,769 | 531.90M |
| 53 | NAMS | NewAmsterdam Pharma Company N.V. | 4.22B | 2.99% | 766,759 | 35.24M |
| 54 | VKTX | Viking Therapeutics, Inc. | 4.19B | -0.35% | 2,463,692 | - |
| 55 | ACLX | Arcellx, Inc. | 4.16B | -1.14% | 678,749 | 35.90M |
| 56 | LEGN | Legend Biotech Corporation | 4.12B | -3.00% | 1,902,179 | 909.05M |
| 57 | GPCR | Structure Therapeutics Inc. | 4.07B | -0.56% | 1,503,765 | - |
| 58 | CNTA | Centessa Pharmaceuticals plc | 3.87B | -2.47% | 2,412,302 | 15.00M |
| 59 | ARQT | Arcutis Biotherapeutics, Inc. | 3.55B | -1.53% | 1,760,718 | 317.93M |
| 60 | VERA | Vera Therapeutics, Inc. | 3.54B | 8.21% | 1,384,423 | - |
| 61 | RARE | Ultragenyx Pharmaceutical Inc. | 3.49B | 0.08% | 1,589,305 | 630.60M |
| 62 | IRON | Disc Medicine, Inc. | 3.47B | -1.87% | 515,585 | - |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.45B | -0.43% | 447,871 | 366.10M |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.40B | 0.92% | 806,480 | 7.50M |
| 65 | MIRM | Mirum Pharmaceuticals, Inc. | 3.34B | -1.10% | 461,128 | 471.79M |
| 66 | CGON | CG Oncology, Inc. | 3.30B | -1.61% | 372,196 | 2.17M |
| 67 | FOLD | Amicus Therapeutics, Inc. | 3.26B | 6.57% | 12,045,523 | 598.70M |
| 68 | APLS | Apellis Pharmaceuticals, Inc. | 3.19B | 1.06% | 1,572,547 | 1.02B |
| 69 | TVTX | Travere Therapeutics, Inc. | 3.12B | -0.51% | 1,451,141 | 435.83M |
| 70 | OCUL | Ocular Therapeutix, Inc. | 3.10B | -0.75% | 2,815,214 | 55.78M |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.09B | -3.63% | 239,158 | 664.23M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 3.08B | -0.80% | 934,989 | 70.79M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.98B | 1.40% | 845,830 | 214.83M |
| 74 | MLYS | Mineralys Therapeutics, Inc. | 2.92B | 2.36% | 2,124,726 | - |
| 75 | LQDA | Liquidia Corporation | 2.90B | 2.42% | 919,786 | 69.22M |
| 76 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.90B | 2.96% | 2,038,913 | 578.20M |
| 77 | NUVB | Nuvation Bio Inc. | 2.89B | 1.93% | 6,065,301 | 26.75M |
| 78 | AAPG | Ascentage Pharma Group International | 2.80B | 1.20% | 639 | 54.52M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.79B | 5.07% | 1,446,937 | 98.68M |
| 80 | WVE | Wave Life Sciences Ltd. | 2.77B | -1.13% | 8,081,039 | 109.23M |
| 81 | DYN | Dyne Therapeutics, Inc. | 2.75B | -0.77% | 4,441,760 | - |
| 82 | BEAM | Beam Therapeutics Inc. | 2.70B | -0.55% | 1,561,960 | 55.70M |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.66B | -14.36% | 7,424,395 | 240.00M |
| 84 | DNLI | Denali Therapeutics Inc. | 2.64B | 3.51% | 1,354,577 | - |
| 85 | SYRE | Spyre Therapeutics, Inc. | 2.61B | -2.15% | 731,167 | - |
| 86 | OLMA | Olema Pharmaceuticals, Inc. | 2.60B | 4.65% | 3,684,398 | - |
| 87 | EWTX | Edgewise Therapeutics, Inc. | 2.50B | 0.81% | 2,535,178 | - |
| 88 | MESO | Mesoblast Limited | 2.36B | -1.79% | 219,197 | 17.20M |
| 89 | ADPT | Adaptive Biotechnologies Corporation | 2.36B | 0.13% | 2,117,241 | 252.75M |
| 90 | HRMY | Harmony Biosciences Holdings, Inc. | 2.33B | 2.32% | 959,005 | 825.94M |
| 91 | IBRX | ImmunityBio, Inc. | 2.32B | 7.76% | 24,853,981 | 82.56M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.26B | -1.01% | 2,008,454 | 2.41B |
| 93 | RXRX | Recursion Pharmaceuticals, Inc. | 2.25B | -5.46% | 17,966,817 | 43.69M |
| 94 | ZBIO | Zenas BioPharma, Inc. | 2.18B | 0.95% | 268,802 | 15.00M |
| 95 | GLPG | Galapagos NV | 2.10B | -2.70% | 62,711 | 336.64M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -0.19% | 959,508 | 265.81M |
| 97 | ZLAB | Zai Lab Limited | 1.98B | -0.28% | 852,405 | 441.63M |
| 98 | NRIX | Nurix Therapeutics, Inc. | 1.93B | - | 1,893,459 | 83.69M |
| 99 | SION | Sionna Therapeutics, Inc. | 1.91B | 2.52% | 202,925 | - |
| 100 | ZYME | Zymeworks Inc. | 1.91B | 2.17% | 656,356 | 134.48M |
| 101 | MAZE | Maze Therapeutics, Inc. | 1.87B | -1.79% | 317,262 | 2.50M |
| 102 | IMCR | Immunocore Holdings plc | 1.86B | 2.79% | 441,299 | 379.59M |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.85B | -2.12% | 1,171,587 | 205.63M |
| 104 | VCEL | Vericel Corporation | 1.85B | -2.33% | 440,613 | 258.72M |
| 105 | CLDX | Celldex Therapeutics, Inc. | 1.83B | -1.54% | 638,008 | 2.60M |
| 106 | MNKD | MannKind Corporation | 1.82B | 2.24% | 3,387,829 | 313.79M |
| 107 | DNTH | Dianthus Therapeutics, Inc. | 1.81B | 1.20% | 520,200 | 3.08M |
| 108 | IMNM | Immunome, Inc. | 1.79B | 0.41% | 1,423,929 | 9.68M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | -0.20% | 1,183,773 | 111.30M |
| 110 | SVRA | Savara Inc. | 1.67B | -0.29% | 2,644,741 | - |
| 111 | TRVI | Trevi Therapeutics, Inc. | 1.64B | -3.04% | 1,935,910 | - |
| 112 | AGIO | Agios Pharmaceuticals, Inc. | 1.59B | -0.69% | 1,182,023 | 44.79M |
| 113 | TSHA | Taysha Gene Therapies, Inc. | 1.59B | 0.52% | 2,541,102 | 6.31M |
| 114 | PHVS | Pharvaris N.V. | 1.57B | 0.75% | 367,420 | - |
| 115 | ATAI | Atai Beckley N.V. | 1.56B | -2.94% | 4,103,039 | 3.02M |
| 116 | INVA | Innoviva, Inc. | 1.54B | 0.05% | 1,014,347 | 388.52M |
| 117 | BHVN | Biohaven Ltd. | 1.53B | 0.79% | 1,868,100 | - |
| 118 | ARDX | Ardelyx, Inc. | 1.51B | 5.25% | 3,758,508 | 398.23M |
| 119 | CAPR | Capricor Therapeutics, Inc. | 1.50B | -4.27% | 1,785,553 | 11.13M |
| 120 | UPB | Upstream Bio, Inc. | 1.47B | -1.20% | 305,149 | 2.80M |
| 121 | ORKA | Oruka Therapeutics, Inc. | 1.46B | -0.13% | 681,013 | - |
| 122 | FTRE | Fortrea Holdings Inc. | 1.45B | 1.09% | 1,270,599 | 2.76B |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.44B | 5.18% | 312,802 | - |
| 124 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.44B | 0.23% | 785,574 | -665.00K |
| 125 | RLAY | Relay Therapeutics, Inc. | 1.39B | 3.08% | 2,845,755 | 8.36M |
| 126 | SANA | Sana Biotechnology, Inc. | 1.37B | 2.80% | 8,095,466 | - |
| 127 | MBX | MBX Biosciences, Inc. | 1.34B | 5.03% | 450,407 | - |
| 128 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.32B | -0.68% | 719,751 | 42.34M |
| 129 | PGEN | Precigen, Inc. | 1.31B | 1.93% | 3,723,041 | 6.31M |
| 130 | KOD | Kodiak Sciences Inc. | 1.26B | -1.33% | 423,333 | - |
| 131 | TNGX | Tango Therapeutics, Inc. | 1.26B | 2.75% | 2,689,011 | 66.50M |
| 132 | ANAB | AnaptysBio, Inc. | 1.24B | -1.83% | 309,170 | 169.47M |
| 133 | MNMD | Mind Medicine (MindMed) Inc. | 1.24B | -0.32% | 1,176,371 | - |
| 134 | IMTX | Immatics N.V. | 1.22B | - | 238,212 | 99.45M |
| 135 | QURE | uniQure N.V. | 1.22B | -1.22% | 1,850,640 | 15.75M |
| 136 | TYRA | Tyra Biosciences, Inc. | 1.21B | -0.79% | 259,244 | - |
| 137 | ALMS | Alumis Inc. | 1.20B | -1.03% | 799,648 | 22.12M |
| 138 | OCS | Oculis Holding AG | 1.20B | -0.72% | 91,801 | 992.00K |
| 139 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | 2.28% | 1,679,223 | 266.14M |
| 140 | XNCR | Xencor, Inc. | 1.18B | -3.17% | 507,333 | 150.13M |
| 141 | PHAR | Pharming Group N.V. | 1.18B | 1.41% | 58,789 | 362.27M |
| 142 | PVLA | Palvella Therapeutics, Inc. | 1.17B | 1.86% | 189,129 | - |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.16B | -3.21% | 179,885 | 1.40M |
| 144 | SEPN | Septerna, Inc. | 1.14B | -2.94% | 164,840 | 22.05M |
| 145 | CVAC | CureVac N.V. | 1.14B | -1.37% | 644,387 | 83.00M |
| 146 | NKTR | Nektar Therapeutics | 1.11B | 7.00% | 705,872 | 62.60M |
| 147 | NBTX | Nanobiotix S.A. | 1.10B | -2.32% | 29,392 | 11.93M |
| 148 | ABCL | AbCellera Biologics Inc. | 1.08B | -3.21% | 2,646,667 | 35.33M |
| 149 | MDXG | MiMedx Group, Inc. | 1.07B | 0.98% | 643,574 | 393.44M |
| 150 | NVAX | Novavax, Inc. | 1.07B | -1.79% | 2,922,474 | 1.06B |
| 151 | GLUE | Monte Rosa Therapeutics, Inc. | 1.06B | -1.51% | 559,042 | 181.54M |
| 152 | MLTX | MoonLake Immunotherapeutics | 1.06B | 5.12% | 2,513,381 | - |
| 153 | NTLA | Intellia Therapeutics, Inc. | 1.04B | -5.55% | 3,405,264 | 57.53M |
| 154 | ERAS | Erasca, Inc. | 1.02B | 6.51% | 1,805,042 | - |
| 155 | URGN | UroGen Pharma Ltd. | 1.02B | -2.50% | 444,683 | 96.52M |
| 156 | RAPT | RAPT Therapeutics, Inc. | 1.02B | 4.31% | 537,807 | - |
| 157 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | -0.07% | 1,244,436 | 147.19M |
| 158 | BCAX | Bicara Therapeutics Inc. | 1.01B | -1.96% | 2,094,449 | - |
| 159 | SPRY | ARS Pharmaceuticals, Inc. | 1.01B | -8.73% | 2,516,511 | 142.77M |
| 160 | AVBP | ArriVent BioPharma, Inc. | 1.01B | 0.41% | 209,767 | - |
| 161 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.01B | -2.34% | 124,156 | - |
| 162 | ELVN | Enliven Therapeutics, Inc. | 1.00B | -10.18% | 1,407,974 | - |
| 163 | VIR | Vir Biotechnology, Inc. | 930.75M | 0.90% | 1,212,093 | 16.86M |
| 164 | TBPH | Theravance Biopharma, Inc. | 920.72M | 2.77% | 509,102 | 80.33M |
| 165 | MRVI | Maravai LifeSciences Holdings, Inc. | 920.54M | -2.96% | 1,611,473 | 192.44M |
| 166 | JANX | Janux Therapeutics, Inc. | 920.26M | -0.39% | 1,904,750 | 10.00M |
| 167 | CMPX | Compass Therapeutics, Inc. | 917.77M | -4.27% | 1,181,460 | 850.00K |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 913.51M | -3.20% | 1,038,450 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 905.85M | 0.86% | 1,568,693 | 14.61M |
| 170 | CRMD | CorMedix Inc. | 905.29M | -2.13% | 3,554,733 | 214.30M |
| 171 | MPLT | MapLight Therapeutics, Inc. | 903.38M | 2.99% | 180,681 | - |
| 172 | KURA | Kura Oncology, Inc. | 889.32M | -2.29% | 1,472,717 | 104.03M |
| 173 | IOVA | Iovance Biotherapeutics, Inc. | 873.33M | -2.22% | 10,614,037 | 250.43M |
| 174 | GERN | Geron Corporation | 868.16M | -2.16% | 10,466,351 | 183.40M |
| 175 | YDES | YD Bio Limited | 860.71M | -2.63% | 64,834 | 510.36K |
| 176 | DAWN | Day One Biopharmaceuticals, Inc. | 858.37M | -0.71% | 1,116,982 | 133.67M |
| 177 | KALV | KalVista Pharmaceuticals, Inc. | 854.74M | 0.06% | 598,217 | 1.43M |
| 178 | IVA | Inventiva S.A. | 843.15M | -0.67% | 186,188 | 19.93M |
| 179 | GOSS | Gossamer Bio, Inc. | 833.24M | -0.55% | 3,477,096 | 44.05M |
| 180 | GHRS | GH Research PLC | 808.55M | -5.54% | 244,812 | - |
| 181 | ARVN | Arvinas, Inc. | 807.94M | 0.08% | 795,227 | 312.30M |
| 182 | REPL | Replimune Group, Inc. | 798.55M | 3.14% | 1,373,715 | - |
| 183 | VALN | Valneva SE | 751.91M | -3.02% | 16,341 | 211.09M |
| 184 | VSTM | Verastem, Inc. | 741.72M | 1.91% | 1,608,057 | 13.38M |
| 185 | ANNX | Annexon, Inc. | 740.81M | -1.39% | 5,562,693 | - |
| 186 | RIGL | Rigel Pharmaceuticals, Inc. | 740.21M | -3.02% | 527,178 | 282.08M |
| 187 | ATXS | Astria Therapeutics, Inc. | 738.11M | 0.15% | 1,176,435 | 706.00K |
| 188 | LYEL | Lyell Immunopharma, Inc. | 731.18M | 3.14% | 64,901 | 41.00K |
| 189 | PRME | Prime Medicine, Inc. | 725.86M | -3.98% | 2,174,131 | 5.98M |
| 190 | OMER | Omeros Corporation | 719.64M | -4.15% | 1,117,946 | - |
| 191 | MGTX | MeiraGTx Holdings plc | 717.98M | 2.29% | 1,243,511 | 27.42M |
| 192 | LXEO | Lexeo Therapeutics, Inc. | 713.09M | -0.31% | 681,920 | - |
| 193 | CTMX | CytomX Therapeutics, Inc. | 709.93M | 3.20% | 1,716,911 | 113.63M |
| 194 | CGEM | Cullinan Therapeutics, Inc. | 704.19M | -3.72% | 937,431 | - |
| 195 | FULC | Fulcrum Therapeutics, Inc. | 703.54M | 1.56% | 1,627,203 | 80.00M |
| 196 | RGNX | REGENXBIO Inc. | 702.14M | 7.94% | 604,467 | 161.32M |
| 197 | GYRE | Gyre Therapeutics, Inc. | 698.95M | -2.29% | 73,759 | 107.27M |
| 198 | JBIO | Jade Biosciences, Inc. | 689.14M | 0.94% | 285,146 | - |
| 199 | DBVT | DBV Technologies S.A. | 679.11M | -5.33% | 311,311 | 5.50M |
| 200 | PROK | ProKidney Corp. | 664.84M | -0.45% | 816,187 | 744.00K |
| 201 | KROS | Keros Therapeutics, Inc. | 655.33M | -0.83% | 343,330 | 246.72M |
| 202 | DRUG | Bright Minds Biosciences Inc. | 654.52M | -5.42% | 84,168 | - |
| 203 | CRVS | Corvus Pharmaceuticals, Inc. | 625.09M | -0.36% | 2,296,180 | - |
| 204 | FDMT | 4D Molecular Therapeutics, Inc. | 619.34M | -0.73% | 1,019,359 | 120.00K |
| 205 | VTYX | Ventyx Biosciences, Inc. | 584.43M | -3.65% | 1,854,412 | - |
| 206 | ASMB | Assembly Biosciences, Inc. | 571.00M | 0.61% | 178,410 | 37.19M |
| 207 | EVMN | Evommune, Inc. | 567.75M | -8.53% | 123,849 | 13.00M |
| 208 | LENZ | LENZ Therapeutics, Inc. | 567.60M | -25.96% | 6,627,956 | 17.50M |
| 209 | ENGN | enGene Holdings Inc. | 565.74M | -5.16% | 316,280 | - |
| 210 | PRTA | Prothena Corporation plc | 557.68M | 0.29% | 455,795 | 11.79M |
| 211 | ALT | Altimmune, Inc. | 549.88M | -1.31% | 6,368,671 | 20.00K |
| 212 | ABSI | Absci Corporation | 547.35M | -5.21% | 4,872,586 | 2.82M |
| 213 | IVVD | Invivyd, Inc. | 540.84M | -2.52% | 2,766,979 | 50.04M |
| 214 | DSGN | Design Therapeutics, Inc. | 537.17M | 2.06% | 136,785 | - |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 530.85M | -5.66% | 893,413 | 180.61M |
| 216 | ADCT | ADC Therapeutics SA | 524.00M | 1.20% | 1,665,928 | 75.21M |
| 217 | NAGE | Niagen Bioscience, Inc. | 522.18M | -1.66% | 710,238 | 124.71M |
| 218 | BCYC | Bicycle Therapeutics plc | 516.79M | 0.27% | 156,429 | 28.34M |
| 219 | MNPR | Monopar Therapeutics Inc. | 498.55M | -3.17% | 246,265 | - |
| 220 | DMAC | DiaMedica Therapeutics Inc. | 489.01M | 0.54% | 606,075 | - |
| 221 | LBRX | LB Pharmaceuticals Inc | 483.85M | -5.46% | 376,970 | - |
| 222 | LXRX | Lexicon Pharmaceuticals, Inc. | 472.42M | -1.52% | 1,080,295 | 70.86M |
| 223 | ANRO | Alto Neuroscience, Inc. | 470.03M | 3.07% | 217,644 | - |
| 224 | ZVRA | Zevra Therapeutics, Inc. | 468.96M | -0.72% | 624,195 | 84.39M |
| 225 | NBP | NovaBridge Biosciences | 459.91M | 1.79% | 348,139 | - |
| 226 | SLDB | Solid Biosciences Inc. | 457.33M | - | 648,281 | - |
| 227 | DRTS | Alpha Tau Medical Ltd. | 430.58M | 1.81% | 172,573 | - |
| 228 | AUTL | Autolus Therapeutics plc | 428.49M | 1.26% | 3,446,999 | 51.13M |
| 229 | VTVT | vTv Therapeutics Inc. | 426.49M | 0.79% | 5,903 | 17.00K |
| 230 | ENTA | Enanta Pharmaceuticals, Inc. | 425.15M | 4.17% | 254,919 | 65.32M |
| 231 | OCGN | Ocugen, Inc. | 424.76M | 4.62% | 4,047,437 | 5.37M |
| 232 | TENX | Tenax Therapeutics, Inc. | 420.71M | 5.28% | 229,387 | - |
| 233 | AURA | Aura Biosciences, Inc. | 415.31M | 0.46% | 155,903 | - |
| 234 | BNTC | Benitec Biopharma Inc. | 405.67M | -7.56% | 234,157 | - |
| 235 | GALT | Galectin Therapeutics Inc. | 402.95M | 9.46% | 760,702 | - |
| 236 | LCTX | Lineage Cell Therapeutics, Inc. | 402.26M | -2.92% | 801,963 | 10.82M |
| 237 | TRDA | Entrada Therapeutics, Inc. | 397.70M | 2.59% | 164,889 | 61.52M |
| 238 | PRTC | PureTech Health plc | 393.81M | -0.30% | 481 | 6.39M |
| 239 | IMRX | Immuneering Corporation | 392.59M | -1.94% | 550,844 | - |
| 240 | PEPG | PepGen Inc. | 389.11M | -1.39% | 314,348 | - |
| 241 | KYTX | Kyverna Therapeutics, Inc. | 384.53M | 5.02% | 1,104,109 | - |
| 242 | FBRX | Forte Biosciences, Inc. | 381.06M | -5.65% | 211,566 | - |
| 243 | TECX | Tectonic Therapeutic, Inc. | 369.83M | 1.49% | 132,114 | - |
| 244 | VNDA | Vanda Pharmaceuticals Inc. | 368.17M | -5.61% | 1,959,903 | 212.07M |
| 245 | IMMP | Immutep Limited | 366.99M | -1.90% | 418,311 | 3.31M |
| 246 | RCKT | Rocket Pharmaceuticals, Inc. | 366.87M | -1.74% | 1,618,164 | - |
| 247 | AVXL | Anavex Life Sciences Corp. | 359.18M | -2.19% | 4,861,956 | - |
| 248 | NMRA | Neumora Therapeutics, Inc. | 355.17M | 0.97% | 617,482 | - |
| 249 | NBY | NovaBay Pharmaceuticals, Inc. | 352.83M | -0.36% | 814,483 | 10.30M |
| 250 | ACRS | Aclaris Therapeutics, Inc. | 352.12M | -3.27% | 955,814 | 15.74M |
| 251 | CLLS | Cellectis S.A. | 348.93M | -10.34% | 167,785 | 82.55M |
| 252 | CADL | Candel Therapeutics, Inc. | 348.60M | -1.85% | 1,414,634 | - |
| 253 | LRMR | Larimar Therapeutics, Inc. | 346.64M | 0.75% | 680,865 | - |
| 254 | MREO | Mereo BioPharma Group plc | 345.32M | -3.56% | 2,212,567 | 500.00K |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 341.88M | 0.77% | 525,553 | 33.98M |
| 256 | CTNM | Contineum Therapeutics, Inc. | 339.39M | -11.02% | 1,503,736 | - |
| 257 | ALLO | Allogene Therapeutics, Inc. | 339.34M | -2.58% | 2,277,101 | 22.00K |
| 258 | AVTX | Avalo Therapeutics, Inc. | 337.29M | -4.66% | 374,670 | 192.00K |
| 259 | CYBN | Cybin Inc. | 333.36M | 6.03% | 898,074 | - |
| 260 | EPRX | Eupraxia Pharmaceuticals Inc. | 325.66M | -2.03% | 87,786 | - |
| 261 | NGNE | Neurogene Inc. | 324.05M | -1.60% | 113,527 | 925.00K |
| 262 | AARD | Aardvark Therapeutics, Inc. | 314.19M | -7.56% | 267,186 | - |
| 263 | XOMA | XOMA Royalty Corporation | 312.30M | -4.97% | 133,627 | 47.11M |
| 264 | ACIU | AC Immune SA | 311.67M | -2.17% | 2,707,739 | 5.48M |
| 265 | OABI | OmniAb, Inc. | 309.50M | -0.46% | 648,152 | 21.09M |
| 266 | GUTS | Fractyl Health, Inc. | 306.98M | -2.61% | 2,995,114 | 3.00K |
| 267 | CAMP | Camp4 Therapeutics Corporation | 304.26M | 7.99% | 242,804 | 3.80M |
| 268 | SLN | Silence Therapeutics plc | 298.52M | -1.86% | 155,847 | 25.83M |
| 269 | RLMD | Relmada Therapeutics, Inc. | 297.73M | -3.10% | 1,569,532 | - |
| 270 | PBYI | Puma Biotechnology, Inc. | 295.29M | 2.27% | 355,313 | 212.00M |
| 271 | TARA | Protara Therapeutics, Inc. | 294.30M | -5.16% | 700,487 | - |
| 272 | ABEO | Abeona Therapeutics Inc. | 290.47M | -2.90% | 1,020,340 | 400.00K |
| 273 | SLS | SELLAS Life Sciences Group, Inc. | 289.16M | 1.00% | 5,728,544 | - |
| 274 | PALI | Palisade Bio, Inc. | 289.07M | -11.82% | 4,554,945 | - |
| 275 | CBIO | Crescent Biopharma, Inc. | 275.45M | -7.97% | 103,587 | - |
| 276 | ALDX | Aldeyra Therapeutics, Inc. | 273.14M | -1.09% | 1,301,062 | - |
| 277 | PYXS | Pyxis Oncology, Inc. | 267.74M | -2.49% | 338,860 | 2.82M |
| 278 | ZURA | Zura Bio Limited | 261.39M | -0.50% | 386,874 | - |
| 279 | FENC | Fennec Pharmaceuticals Inc. | 257.86M | 0.80% | 463,809 | 38.79M |
| 280 | VOR | Vor Biopharma Inc. | 255.34M | 3.13% | 3,396,663 | - |
| 281 | OBIO | Orchestra BioMed Holdings, Inc. | 254.66M | -1.31% | 143,149 | 2.82M |
| 282 | HRTX | Heron Therapeutics, Inc. | 251.21M | - | 1,903,941 | 155.10M |
| 283 | FHTX | Foghorn Therapeutics Inc. | 251.09M | -0.89% | 90,018 | 24.52M |
| 284 | ACHV | Achieve Life Sciences, Inc. | 247.01M | -1.07% | 560,496 | - |
| 285 | EDIT | Editas Medicine, Inc. | 246.98M | -1.17% | 2,263,363 | 46.38M |
| 286 | AVIR | Atea Pharmaceuticals, Inc. | 246.10M | -1.25% | 232,781 | - |
| 287 | PRQR | ProQR Therapeutics N.V. | 245.45M | -1.27% | 567,392 | 18.86M |
| 288 | HUMA | Humacyte, Inc. | 245.33M | - | 2,130,277 | 1.57M |
| 289 | MIST | Milestone Pharmaceuticals Inc. | 244.81M | -18.31% | 28,117,039 | - |
| 290 | MDWD | MediWound Ltd. | 244.25M | -1.09% | 99,544 | 20.93M |
| 291 | VYGR | Voyager Therapeutics, Inc. | 244.08M | -0.45% | 257,528 | 31.32M |
| 292 | CCCC | C4 Therapeutics, Inc. | 239.38M | -2.76% | 1,285,531 | 30.11M |
| 293 | IMMX | Immix Biopharma, Inc. | 237.40M | -4.20% | 1,550,000 | - |
| 294 | QNCX | Quince Therapeutics, Inc. | 234.98M | -4.09% | 957,052 | - |
| 295 | NAUT | Nautilus Biotechnology, Inc. | 233.66M | -6.57% | 247,630 | - |
| 296 | CABA | Cabaletta Bio, Inc. | 227.19M | - | 1,280,857 | - |
| 297 | TNXP | Tonix Pharmaceuticals Holding Corp. | 227.05M | -1.78% | 409,033 | 10.30M |
| 298 | RNAC | Cartesian Therapeutics, Inc. | 221.81M | 0.95% | 173,658 | 1.09M |
| 299 | ARMP | Armata Pharmaceuticals, Inc. | 214.35M | 2.25% | 25,993 | 5.05M |
| 300 | ARCT | Arcturus Therapeutics Holdings Inc. | 211.96M | -0.80% | 680,722 | 97.60M |
| 301 | SRZN | Surrozen, Inc. | 211.63M | 3.70% | 104,613 | 3.60M |
| 302 | TLSA | Tiziana Life Sciences Ltd | 211.51M | 3.49% | 1,230,990 | - |
| 303 | CLYM | Climb Bio, Inc. | 204.55M | 30.43% | 8,375,507 | - |
| 304 | DWTX | Dogwood Therapeutics, Inc. | 202.74M | 6.23% | 74,991 | - |
| 305 | SGMT | Sagimet Biosciences Inc. | 202.61M | -1.58% | 323,415 | - |
| 306 | NTHI | NeOnc Technologies Holdings, Inc. | 198.83M | 8.96% | 43,940 | 59.99K |
| 307 | STTK | Shattuck Labs, Inc. | 196.17M | -4.02% | 159,856 | 1.00M |
| 308 | NVCT | Nuvectis Pharma, Inc. | 194.42M | 0.13% | 77,078 | - |
| 309 | SABS | SAB Biotherapeutics, Inc. | 181.38M | 6.13% | 150,076 | 114.70K |
| 310 | IKT | Inhibikase Therapeutics, Inc. | 180.36M | 0.98% | 642,175 | 1.00 |
| 311 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 179.73M | 0.21% | 497,616 | - |
| 312 | IPHA | Innate Pharma S.A. | 176.57M | -0.54% | 24,154 | 14.84M |
| 313 | ACTU | Actuate Therapeutics, Inc. | 175.25M | 1.62% | 104,664 | - |
| 314 | VTGN | Vistagen Therapeutics, Inc. | 167.86M | 7.59% | 744,448 | 721.00K |
| 315 | CRBU | Caribou Biosciences, Inc. | 167.31M | -3.76% | 1,134,408 | 9.30M |
| 316 | RZLT | Rezolute, Inc. | 166.91M | 28.57% | 35,289,125 | - |
| 317 | KLRS | Kalaris Therapeutics, Inc. | 165.89M | 6.48% | 187,232 | - |
| 318 | CHRS | Coherus Oncology, Inc. | 163.18M | -5.59% | 870,992 | 277.73M |
| 319 | RANI | Rani Therapeutics Holdings, Inc. | 162.84M | -8.84% | 3,363,289 | 1.20M |
| 320 | IRD | Opus Genetics, Inc. | 162.76M | -3.28% | 334,580 | 14.63M |
| 321 | GNLX | Genelux Corporation | 162.70M | -1.70% | 102,153 | 8.00K |
| 322 | ALEC | Alector, Inc. | 162.64M | 2.05% | 1,472,660 | 69.05M |
| 323 | CRDF | Cardiff Oncology, Inc. | 160.99M | -3.43% | 752,598 | 501.00K |
| 324 | GANX | Gain Therapeutics, Inc. | 159.23M | 0.73% | 1,866,256 | - |
| 325 | BDTX | Black Diamond Therapeutics, Inc. | 158.96M | 1.09% | 1,121,433 | 70.00M |
| 326 | MOLN | Molecular Partners AG | 158.85M | -3.46% | 521 | 856.30K |
| 327 | ETHZ | ETHZilla Corporation | 157.80M | -8.50% | 996,767 | 4.11M |
| 328 | MCRB | Seres Therapeutics, Inc. | 153.25M | -1.28% | 44,908 | 351.00K |
| 329 | SGMO | Sangamo Therapeutics, Inc. | 151.42M | -1.98% | 4,438,592 | 32.88M |
| 330 | CDXS | Codexis, Inc. | 150.84M | -2.34% | 800,158 | 52.93M |
| 331 | CGTX | Cognition Therapeutics, Inc. | 149.18M | 4.32% | 1,038,348 | - |
| 332 | GLSI | Greenwich LifeSciences, Inc. | 148.66M | -4.79% | 154,975 | - |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 143.95M | -2.19% | 543,387 | 61.84M |
| 334 | CGEN | Compugen Ltd. | 143.11M | -4.38% | 538,650 | 6.90M |
| 335 | ELTX | Elicio Therapeutics, Inc. | 143.03M | -2.21% | 49,161 | - |
| 336 | MRSN | Mersana Therapeutics, Inc. | 141.71M | 0.43% | 55,493 | 33.18M |
| 337 | SAVA | Cassava Sciences, Inc. | 141.54M | -6.98% | 858,700 | - |
| 338 | TNYA | Tenaya Therapeutics, Inc. | 141.53M | -37.50% | 66,590,996 | - |
| 339 | INO | Inovio Pharmaceuticals, Inc. | 141.53M | -3.29% | 744,381 | 182.34K |
| 340 | PRLD | Prelude Therapeutics Incorporated | 140.90M | 4.91% | 340,068 | 10.50M |
| 341 | CNTB | Connect Biopharma Holdings Limited | 139.76M | 2.88% | 114,722 | 762.00K |
| 342 | UNCY | Unicycive Therapeutics, Inc. | 133.89M | -2.81% | 249,994 | - |
| 343 | NKTX | Nkarta, Inc. | 133.54M | 1.07% | 718,581 | - |
| 344 | FATE | Fate Therapeutics, Inc. | 132.66M | 3.60% | 1,405,874 | 7.14M |
| 345 | SPRO | Spero Therapeutics, Inc. | 130.71M | -1.28% | 287,132 | 40.55M |
| 346 | ATRA | Atara Biotherapeutics, Inc. | 129.75M | 0.98% | 103,303 | 151.93M |
| 347 | ABOS | Acumen Pharmaceuticals, Inc. | 129.63M | 9.18% | 277,157 | - |
| 348 | COYA | Coya Therapeutics, Inc. | 129.31M | -1.12% | 268,373 | 3.99M |
| 349 | AGEN | Agenus Inc. | 128.89M | -7.11% | 836,731 | 106.83M |
| 350 | VRCA | Verrica Pharmaceuticals Inc. | 126.64M | -4.58% | 170,587 | 30.83M |
| 351 | ELDN | Eledon Pharmaceuticals, Inc. | 123.24M | -3.53% | 895,045 | - |
| 352 | ORMP | Oramed Pharmaceuticals Inc. | 122.19M | 1.15% | 170,230 | 2.00M |
| 353 | EXOZ | eXoZymes, Inc. | 120.27M | -9.81% | 6,209 | -700.00 |
| 354 | DTIL | Precision BioSciences, Inc. | 120.12M | 1.42% | 136,773 | 698.00K |
| 355 | KPTI | Karyopharm Therapeutics Inc. | 118.50M | -0.71% | 222,146 | 142.53M |
| 356 | ANIX | Anixa Biosciences, Inc. | 117.84M | -25.42% | 2,157,251 | - |
| 357 | OVID | Ovid Therapeutics Inc. | 116.79M | -0.61% | 885,331 | 6.61M |
| 358 | ACOG | Alpha Cognition Inc. | 115.45M | -8.92% | 110,615 | 7.43M |
| 359 | CNTX | Context Therapeutics Inc. | 110.85M | - | 546,635 | - |
| 360 | ANVS | Annovis Bio, Inc. | 109.46M | 8.97% | 1,044,279 | - |
| 361 | WHWK | Whitehawk Therapeutics, Inc. | 109.34M | -7.20% | 136,125 | 14.38M |
| 362 | SLGL | Sol-Gel Technologies Ltd. | 108.67M | -7.78% | 12,094 | 18.97M |
| 363 | ATOS | Atossa Therapeutics, Inc. | 106.57M | -8.82% | 1,457,035 | - |
| 364 | ONCY | Oncolytics Biotech Inc. | 105.41M | -0.53% | 481,058 | - |
| 365 | ZNTL | Zentalis Pharmaceuticals, Inc. | 101.15M | -3.45% | 365,702 | 26.87M |
| 366 | TTRX | Turn Therapeutics Inc. | 100.41M | 6.23% | 74,950 | - |
| 367 | BMEA | Biomea Fusion, Inc. | 99.69M | -7.24% | 1,202,843 | - |
| 368 | ENTX | Entera Bio Ltd. | 99.05M | -2.26% | 95,808 | 124.00K |
| 369 | VANI | Vivani Medical, Inc. | 98.49M | -2.88% | 191,508 | - |
| 370 | SEER | Seer, Inc. | 98.19M | -2.76% | 295,349 | 16.38M |
| 371 | ANEB | Anebulo Pharmaceuticals, Inc. | 94.08M | 2.23% | 1,022 | - |
| 372 | PSTV | Plus Therapeutics, Inc. | 93.97M | -5.03% | 6,012,272 | 5.26M |
| 373 | CSBR | Champions Oncology, Inc. | 92.66M | 6.67% | 12,373 | 56.88M |
| 374 | RPTX | Repare Therapeutics Inc. | 91.99M | - | 847,712 | 11.87M |
| 375 | FBIO | Fortress Biotech, Inc. | 90.94M | -0.34% | 185,976 | 62.30M |
| 376 | SPRB | Spruce Biosciences, Inc. | 89.27M | -5.67% | 45,022 | 697.00K |
| 377 | VXRT | Vaxart, Inc. | 88.64M | 1.37% | - | 148.20M |
| 378 | MGNX | MacroGenics, Inc. | 88.56M | -0.71% | 661,488 | 127.63M |
| 379 | OTLK | Outlook Therapeutics, Inc. | 87.95M | -1.00% | 1,801,076 | 1.51M |
| 380 | CBUS | Cibus, Inc. | 87.40M | -7.47% | 151,198 | 3.79M |
| 381 | BYSI | BeyondSpring Inc. | 86.77M | -3.21% | 12,352,248 | 1.88M |
| 382 | THAR | Tharimmune, Inc. | 83.76M | -5.53% | 205,312 | - |
| 383 | STRO | Sutro Biopharma, Inc. | 83.69M | 0.20% | 121,570 | 105.65M |
| 384 | ADAG | Adagene Inc. | 82.48M | -0.79% | 80,890 | 103.20K |
| 385 | ALGS | Aligos Therapeutics, Inc. | 81.81M | 15.51% | 194,977 | 2.65M |
| 386 | HYFT | MindWalk Holdings Corp. | 81.69M | -5.35% | 290,608 | 18.21M |
| 387 | ARTV | Artiva Biotherapeutics, Inc. | 81.00M | 5.10% | 80,576 | 251.00K |
| 388 | COEP | Coeptis Therapeutics Holdings, Inc. | 80.80M | -6.83% | 107,597 | 501.00K |
| 389 | ACET | Adicet Bio, Inc. | 80.64M | -3.50% | 3,889,086 | - |
| 390 | TVGN | Tevogen Bio Holdings Inc. | 80.17M | -6.16% | 812,639 | - |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 79.83M | -3.07% | 361,093 | - |
| 392 | ALXO | ALX Oncology Holdings Inc. | 79.70M | -3.29% | 96,689 | - |
| 393 | CRVO | CervoMed Inc. | 78.19M | 3.17% | 15,734 | 6.16M |
| 394 | EQ | Equillium, Inc. | 77.94M | -4.48% | 555,380 | 4.39M |
| 395 | KRRO | Korro Bio, Inc. | 77.50M | 4.18% | 384,412 | 7.37M |
| 396 | OKYO | OKYO Pharma Limited | 77.48M | -4.63% | 179,370 | - |
| 397 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 76.55M | -2.00% | 3,362,250 | - |
| 398 | ATYR | aTyr Pharma, Inc. | 75.99M | 1.33% | 1,558,439 | 190.00K |
| 399 | PLRX | Pliant Therapeutics, Inc. | 75.58M | -6.82% | 1,566,129 | - |
| 400 | MNOV | MediciNova, Inc. | 75.53M | 1.99% | 67,845 | 257.92K |
| 401 | IMUX | Immunic, Inc. | 74.76M | -5.26% | 1,723,195 | - |
| 402 | TIL | Instil Bio, Inc. | 73.52M | -1.09% | 62,082 | - |
| 403 | XBIT | XBiotech Inc. | 73.17M | -5.88% | 51,141 | - |
| 404 | IFRX | InflaRx N.V. | 71.13M | 2.94% | 580,428 | 73.73K |
| 405 | PTHS | Pelthos Therapeutics Inc. | 70.96M | -3.97% | 22,904 | 7.41M |
| 406 | IMA | ImageneBio, Inc. | 69.23M | 0.46% | 98,212 | 800.00K |
| 407 | ESLA | Estrella Immunopharma, Inc. | 66.09M | -4.89% | 54,296 | - |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 65.45M | -1.60% | 160,542 | - |
| 409 | PYPD | PolyPid Ltd. | 65.21M | -1.51% | 45,916 | - |
| 410 | ATHE | Alterity Therapeutics Limited | 65.00M | -3.80% | 17,147 | 3.57M |
| 411 | OSTX | OS Therapies Incorporated | 63.74M | -10.84% | 1,322,702 | - |
| 412 | LITS | Lite Strategy, Inc. | 62.90M | -5.52% | 228,604 | - |
| 413 | CALC | CalciMedica, Inc. | 62.39M | -5.66% | 61,151 | - |
| 414 | NTRB | Nutriband Inc. | 62.00M | 2.62% | 10,749 | 2.28M |
| 415 | MGX | Metagenomi, Inc. | 61.95M | -5.17% | 425,380 | 30.91M |
| 416 | INKT | MiNK Therapeutics, Inc. | 58.30M | -1.04% | 11,377 | - |
| 417 | NRXP | NRx Pharmaceuticals, Inc. | 58.16M | -5.91% | 593,849 | 242.00K |
| 418 | IOBT | IO Biotech, Inc. | 58.11M | -5.00% | 335,382 | - |
| 419 | TCRX | TScan Therapeutics, Inc. | 57.32M | -5.61% | 363,376 | 8.42M |
| 420 | ICCC | ImmuCell Corporation | 56.17M | 2.31% | 9,276 | 27.77M |
| 421 | INMB | INmune Bio, Inc. | 53.44M | -6.07% | 463,824 | 50.00K |
| 422 | HOWL | Werewolf Therapeutics, Inc. | 53.39M | 0.92% | 376,856 | 1.14M |
| 423 | PDSB | PDS Biotechnology Corporation | 53.30M | -3.55% | 536,283 | - |
| 424 | HURA | TuHURA Biosciences, Inc. | 52.54M | -0.97% | 564,630 | - |
| 425 | EVAX | Evaxion A/S | 51.79M | -3.72% | 70,859 | 7.65M |
| 426 | CVM | CEL-SCI Corporation | 50.98M | -1.85% | 31,380 | - |
| 427 | ANL | Adlai Nortye Ltd. | 50.92M | 7.81% | 46,351 | 1.94M |
| 428 | IBO | Impact BioMedical Inc. | 50.80M | -0.51% | 141,927 | 25.00K |
| 429 | MAIA | MAIA Biotechnology, Inc. | 50.36M | -17.07% | 1,923,655 | - |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 49.85M | -2.03% | 185,188 | - |
| 431 | ABVC | ABVC BioPharma, Inc. | 49.73M | -6.22% | 110,481 | 797.92K |
| 432 | JSPR | Jasper Therapeutics, Inc. | 49.53M | -3.80% | 573,534 | - |
| 433 | IPSC | Century Therapeutics, Inc. | 48.69M | -5.73% | 501,966 | 113.34M |
| 434 | BCAB | BioAtla, Inc. | 48.47M | 5.26% | 979,363 | 11.00M |
| 435 | PTN | Palatin Technologies, Inc. | 47.18M | 10.46% | 43,293 | 8.85M |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 47.11M | 4.14% | 432,201 | 90.00K |
| 437 | GRCE | Grace Therapeutics, Inc. | 46.77M | -1.49% | 86,675 | - |
| 438 | KZR | Kezar Life Sciences, Inc. | 45.70M | -0.95% | 41,519 | - |
| 439 | CELU | Celularity Inc. | 45.33M | -4.19% | 95,310 | 40.58M |
| 440 | BTAI | BioXcel Therapeutics, Inc. | 43.96M | -2.90% | 451,322 | 752.00K |
| 441 | IBIO | iBio, Inc. | 43.63M | -19.83% | 8,083,540 | 500.00K |
| 442 | GLTO | Galecto, Inc. | 42.47M | 10.31% | 105,106 | - |
| 443 | OKUR | OnKure Therapeutics, Inc. | 41.59M | -4.95% | 50,018 | - |
| 444 | TVRD | Tvardi Therapeutics, Inc. | 41.37M | -1.78% | 84,123 | - |
| 445 | RNTX | Rein Therapeutics Inc. | 40.74M | 0.65% | 1,005,968 | - |
| 446 | XCUR | Exicure, Inc. | 40.47M | 4.61% | 224,241 | 500.00K |
| 447 | LTRN | Lantern Pharma Inc. | 40.26M | -3.74% | 25,574 | - |
| 448 | VERU | Veru Inc. | 39.00M | -5.08% | 97,158 | 16.89M |
| 449 | JUNS | Jupiter Neurosciences, Inc. | 38.56M | -5.08% | 42,214 | - |
| 450 | CUE | Cue Biopharma, Inc. | 38.35M | -1.24% | 395,990 | 7.10M |
| 451 | NXTC | NextCure, Inc. | 38.30M | -0.75% | 36,788 | - |
| 452 | GBIO | Generation Bio Co. | 36.59M | 0.74% | 14,155 | 15.27M |
| 453 | QTTB | Q32 Bio Inc. | 36.42M | -6.92% | 329,104 | - |
| 454 | XLO | Xilio Therapeutics, Inc. | 35.76M | -4.11% | 678,391 | 31.80M |
| 455 | QNTM | Quantum BioPharma Ltd. | 35.31M | -4.67% | 19,393 | - |
| 456 | DARE | Daré Bioscience, Inc. | 35.29M | 18.18% | 2,186,857 | -57.13K |
| 457 | RADX | Radiopharm Theranostics Limited | 35.24M | -0.47% | 839 | 8.20M |
| 458 | RNXT | RenovoRx, Inc. | 35.18M | -3.31% | 179,181 | 928.00K |
| 459 | SKYE | Skye Bioscience, Inc. | 34.94M | -5.22% | 362,902 | - |
| 460 | APLM | Apollomics, Inc. | 34.45M | -3.95% | 25,436 | 198.00K |
| 461 | SNTI | Senti Biosciences, Inc. | 34.44M | -7.42% | 1,333,594 | - |
| 462 | FGEN | FibroGen, Inc. | 33.90M | -3.68% | 11,820 | 8.30M |
| 463 | SER | Serina Therapeutics, Inc. | 33.27M | -0.64% | 13,114 | 116.00K |
| 464 | GNTA | Genenta Science S.p.A. | 33.04M | -14.55% | 118,391 | - |
| 465 | DYAI | Dyadic International, Inc. | 32.95M | -1.41% | 31,386 | 3.34M |
| 466 | ANTX | AN2 Therapeutics, Inc. | 32.88M | 0.84% | 74,960 | - |
| 467 | IGC | IGC Pharma, Inc. | 32.29M | 6.04% | 1,419,571 | 1.11M |
| 468 | PASG | Passage Bio, Inc. | 31.14M | -8.29% | 77,325 | - |
| 469 | RLYB | Rallybio Corporation | 30.92M | -1.28% | 40,537 | 674.00K |
| 470 | CING | Cingulate Inc. | 30.00M | 6.22% | 215,133 | - |
| 471 | LEXX | Lexaria Bioscience Corp. | 29.78M | 8.94% | 571,654 | 705.92K |
| 472 | KLTO | Klotho Neurosciences, Inc. | 29.04M | -5.61% | 949,729 | - |
| 473 | PLUR | Pluri Inc. | 28.50M | -0.32% | 12,934 | 1.33M |
| 474 | INTS | Intensity Therapeutics, Inc. | 28.23M | -20.34% | 7,034,665 | - |
| 475 | NRXS | NeurAxis, Inc. | 28.23M | 0.76% | 40,124 | 3.36M |
| 476 | BRNS | Barinthus Biotherapeutics plc | 27.74M | -5.71% | 140,152 | 14.97M |
| 477 | NERV | Minerva Neurosciences, Inc. | 27.13M | -4.90% | 37,299 | - |
| 478 | BOLD | Boundless Bio, Inc. | 26.19M | 1.74% | 45,100 | - |
| 479 | KTTA | Pasithea Therapeutics Corp. | 25.31M | 0.89% | 366,179 | - |
| 480 | LNAI | Lunai Bioworks Inc. | 25.07M | -7.76% | 231,115 | - |
| 481 | HYPD | Hyperion DeFi, Inc. | 24.93M | -7.94% | 392,064 | 345.32K |
| 482 | PLRZ | Polyrizon Ltd. | 24.89M | 1.61% | 332,365 | - |
| 483 | MRKR | Marker Therapeutics, Inc. | 24.51M | 3.52% | 252,977 | 4.69M |
| 484 | FBLG | FibroBiologics, Inc. | 24.08M | 13.00% | 1,894,079 | - |
| 485 | ITRM | Iterum Therapeutics plc | 23.75M | -4.13% | 543,507 | 390.00K |
| 486 | CLGN | CollPlant Biotechnologies Ltd. | 23.13M | -4.74% | 24,107 | 2.48M |
| 487 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.10M | -3.57% | 52,064 | - |
| 488 | LIMN | Liminatus Pharma, Inc. | 22.97M | -1.53% | 56,125 | - |
| 489 | CVKD | Cadrenal Therapeutics, Inc. | 22.83M | - | 104,988 | - |
| 490 | ENLV | Enlivex Therapeutics Ltd. | 22.57M | -3.14% | 923,533 | - |
| 491 | NNVC | NanoViricides, Inc. | 22.50M | -3.85% | 317,173 | - |
| 492 | NRSN | NeuroSense Therapeutics Ltd. | 22.29M | - | 152,247 | - |
| 493 | NEUP | Neuphoria Therapeutics Inc. | 21.94M | 2.51% | 104,730 | 15.65M |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 20.69M | -3.45% | 194,217 | - |
| 495 | MTVA | MetaVia Inc. | 20.49M | 8.76% | 81,390 | - |
| 496 | BCTX | BriaCell Therapeutics Corp. | 19.51M | -7.47% | 54,034 | - |
| 497 | PMN | ProMIS Neurosciences, Inc. | 19.35M | 2.68% | 15,197 | - |
| 498 | GDTC | CytoMed Therapeutics Limited | 19.16M | -0.60% | 10,772 | 573.19K |
| 499 | KZIA | Kazia Therapeutics Limited | 19.13M | -20.26% | 236,944 | 1.20M |
| 500 | APVO | Aptevo Therapeutics Inc. | 19.04M | -2.59% | 706,612 | - |
| 501 | TRAW | Traws Pharma, Inc. | 18.62M | - | 208,426 | 2.85M |
| 502 | HOTH | Hoth Therapeutics, Inc. | 18.15M | -3.31% | 72,246 | - |
| 503 | ALLR | Allarity Therapeutics, Inc. | 18.03M | -0.87% | 76,490 | - |
| 504 | CASI | CASI Pharmaceuticals, Inc. | 17.73M | -7.70% | 18,168 | 26.85M |
| 505 | LSTA | Lisata Therapeutics, Inc. | 17.64M | -1.96% | 13,715 | 1.07M |
| 506 | LPCN | Lipocine Inc. | 17.60M | -0.31% | 18,184 | 4.32M |
| 507 | APLT | Applied Therapeutics, Inc. | 16.93M | -45.92% | 38,555,509 | 1.00M |
| 508 | PULM | Pulmatrix, Inc. | 16.73M | 15.66% | 35,621 | 3.00K |
| 509 | SNGX | Soligenix, Inc. | 16.64M | 1.23% | 355,893 | 2.34K |
| 510 | OSRH | OSR Holdings, Inc. | 16.43M | -1.60% | 177,984 | -90.52K |
| 511 | CANF | Can-Fite BioPharma Ltd. | 15.97M | -2.18% | 640,961 | 560.00K |
| 512 | ABP | Abpro Holdings, Inc. | 15.94M | -1.01% | 31,606 | 183.00K |
| 513 | NCNA | NuCana plc | 15.48M | -8.15% | 67,336 | - |
| 514 | ATHA | Athira Pharma, Inc. | 15.46M | -0.76% | 17,973 | - |
| 515 | BCDA | BioCardia, Inc. | 15.39M | -1.36% | 37,072 | 3.00K |
| 516 | CLRB | Cellectar Biosciences, Inc. | 15.35M | -4.23% | 50,420 | - |
| 517 | TPST | Tempest Therapeutics, Inc. | 15.32M | -1.58% | 49,736 | - |
| 518 | PCSA | Processa Pharmaceuticals, Inc. | 15.29M | -0.74% | 607,133 | - |
| 519 | CRIS | Curis, Inc. | 15.00M | -10.08% | 137,543 | 11.65M |
| 520 | KAPA | Kairos Pharma, Ltd. | 14.99M | -11.11% | 317,943 | - |
| 521 | COCP | Cocrystal Pharma, Inc. | 14.47M | -0.94% | 51,943 | - |
| 522 | AKTX | Akari Therapeutics, Plc | 13.92M | -5.02% | 500,811 | - |
| 523 | BLRX | BioLineRx Ltd. | 13.83M | 2.48% | 10,949 | 12.74M |
| 524 | CMMB | Chemomab Therapeutics Ltd. | 13.66M | -5.93% | 55,330 | - |
| 525 | NCEL | NewcelX Ltd. | 13.26M | -12.61% | 113,969 | - |
| 526 | LGVN | Longeveron Inc. | 12.99M | -2.90% | 304,436 | 1.44M |
| 527 | SYBX | Synlogic, Inc. | 12.99M | 0.91% | 26,483 | 8.00K |
| 528 | IMNN | Imunon, Inc. | 12.74M | 0.48% | 24,497 | - |
| 529 | VYNE | VYNE Therapeutics Inc. | 12.50M | -7.28% | 1,239,398 | 524.00K |
| 530 | EDSA | Edesa Biotech, Inc. | 12.25M | -1.69% | 39,816 | - |
| 531 | PHIO | Phio Pharmaceuticals Corp. | 12.06M | -1.75% | 183,824 | - |
| 532 | ICU | SeaStar Medical Holding Corporation | 11.58M | -5.81% | 656,138 | 881.00K |
| 533 | GOVX | GeoVax Labs, Inc. | 11.13M | -3.33% | 503,448 | 3.35M |
| 534 | BIVI | BioVie Inc. | 10.93M | -3.97% | 71,193 | - |
| 535 | SNSE | Sensei Biotherapeutics, Inc. | 10.78M | -5.00% | 22,589 | - |
| 536 | CLDI | Calidi Biotherapeutics, Inc. | 10.68M | -0.68% | 39,943 | - |
| 537 | ERNA | Ernexa Therapeutics Inc. | 10.67M | -8.11% | 31,966 | 1,000.00 |
| 538 | APM | Aptorum Group Limited | 10.59M | -2.26% | 33,699 | - |
| 539 | PPCB | Propanc Biopharma, Inc. | 10.54M | -2.27% | 19,934 | - |
| 540 | BOLT | Bolt Biotherapeutics, Inc. | 10.38M | -7.68% | 74,274 | 5.20M |
| 541 | ASBP | Aspire Biopharma Holdings, Inc. | 10.21M | -9.09% | 55,477,523 | 1.94K |
| 542 | MBRX | Moleculin Biotech, Inc. | 10.14M | -0.40% | 193,897 | - |
| 543 | BRTX | BioRestorative Therapies, Inc. | 9.85M | 0.91% | 11,760 | 383.40K |
| 544 | GRDX | GridAI Technologies Corp. | 9.80M | -6.84% | 50,634 | - |
| 545 | AEON | AEON Biopharma, Inc. | 9.73M | 8.17% | 241,228 | - |
| 546 | EVGN | Evogene Ltd. | 9.68M | -0.92% | 22,362 | 8.02M |
| 547 | TCRT | Alaunos Therapeutics, Inc. | 9.51M | -0.23% | 51,534 | 6.00K |
| 548 | SLXN | Silexion Therapeutics Corp | 8.79M | -7.57% | 24,510 | - |
| 549 | MBIO | Mustang Bio, Inc. | 8.72M | -2.05% | 71,467 | - |
| 550 | RNAZ | TransCode Therapeutics, Inc. | 8.72M | -8.73% | 17,177 | - |
| 551 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.64M | -9.33% | 41,735 | - |
| 552 | ACXP | Acurx Pharmaceuticals, Inc. | 8.49M | -0.97% | 33,337 | - |
| 553 | ALZN | Alzamend Neuro, Inc. | 8.25M | -0.46% | 54,635 | - |
| 554 | XTLB | XTL Biopharmaceuticals Ltd. | 8.24M | - | 9,280 | 451.00K |
| 555 | ADXN | Addex Therapeutics Ltd | 8.22M | -3.09% | 104 | 198.82K |
| 556 | PPBT | Purple Biotech Ltd | 8.11M | -8.56% | 531,273 | - |
| 557 | CELZ | Creative Medical Technology Holdings, Inc. | 7.95M | -2.71% | 52,122 | 6.00K |
| 558 | KPRX | Kiora Pharmaceuticals, Inc. | 7.83M | -0.23% | 13,201 | 20.00K |
| 559 | INAB | IN8bio, Inc. | 7.79M | -2.89% | 86,114 | - |
| 560 | TOVX | Theriva Biologics, Inc. | 7.33M | -6.58% | 1,840,232 | - |
| 561 | KALA | KALA BIO, Inc. | 7.24M | -2.82% | 1,392,309 | - |
| 562 | IMRN | Immuron Limited | 7.22M | -2.86% | 52,985 | 4.78M |
| 563 | ADIL | Adial Pharmaceuticals, Inc. | 7.09M | -0.50% | 267,229 | - |
| 564 | BGMS | Bio Green Med Solution, Inc. | 7.06M | -4.00% | 16,562 | 81.00K |
| 565 | GTBP | GT Biopharma, Inc. | 7.02M | 1.51% | 942,103 | - |
| 566 | PMCB | PharmaCyte Biotech, Inc. | 6.93M | - | 700,635 | - |
| 567 | LYRA | Lyra Therapeutics, Inc. | 6.45M | -9.13% | 65,057 | 600.00K |
| 568 | GNPX | Genprex, Inc. | 6.45M | -12.35% | 405,977 | - |
| 569 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.43M | -4.86% | 26,269 | 15.78K |
| 570 | REVB | Revelation Biosciences, Inc. | 6.22M | -8.70% | 245,182 | - |
| 571 | APRE | Aprea Therapeutics, Inc. | 5.90M | -1.07% | 84,162 | 488.24K |
| 572 | VIVS | VivoSim Labs, Inc. | 5.79M | -1.77% | 79,489 | 140.00K |
| 573 | SILO | Silo Pharma, Inc. | 5.79M | -2.32% | 178,479 | 72.10K |
| 574 | GLMD | Galmed Pharmaceuticals Ltd. | 5.75M | 1.94% | 91,243 | - |
| 575 | CYCN | Cyclerion Therapeutics, Inc. | 5.75M | -10.12% | 64,271 | 2.86M |
| 576 | XBIO | Xenetic Biosciences, Inc. | 5.59M | 0.83% | 21,674 | 2.86M |
| 577 | JAGX | Jaguar Health, Inc. | 5.53M | -6.25% | 189,260 | 11.79M |
| 578 | ENSC | Ensysce Biosciences, Inc. | 5.18M | 0.35% | 89,563 | 4.49M |
| 579 | MTNB | Matinas BioPharma Holdings, Inc. | 5.06M | -0.37% | 19,355 | - |
| 580 | HCWB | HCW Biologics Inc. | 4.89M | -8.12% | 211,698 | 422.03K |
| 581 | CNSP | CNS Pharmaceuticals, Inc. | 4.83M | 1.78% | 13,141 | - |
| 582 | SLRX | Salarius Pharmaceuticals, Inc. | 4.57M | -3.68% | 129,486 | - |
| 583 | CMND | Clearmind Medicine Inc. | 4.46M | 3.63% | 11,472,082 | - |
| 584 | INDP | Indaptus Therapeutics, Inc. | 4.27M | -5.06% | 13,622 | - |
| 585 | XRTX | XORTX Therapeutics Inc. | 4.21M | -0.16% | 37,815 | - |
| 586 | ARTL | Artelo Biosciences, Inc. | 3.94M | 0.52% | 308,411 | - |
| 587 | SCNI | Scinai Immunotherapeutics Ltd. | 3.83M | -2.43% | 18,161 | 1.15M |
| 588 | OGEN | Oragenics, Inc. | 3.81M | -1.79% | 403,335 | - |
| 589 | AZTR | Azitra, Inc. | 3.70M | -5.56% | 149,210 | 7.50K |
| 590 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.61M | -2.32% | 94,402 | 1.36M |
| 591 | ONCO | Onconetix, Inc. | 3.59M | -0.43% | 46,885 | 1.22M |
| 592 | PHGE | BiomX Inc. | 3.48M | -6.94% | 140,892 | - |
| 593 | ENVB | Enveric Biosciences, Inc. | 3.24M | -0.18% | 294,050 | - |
| 594 | PTIX | Protagenic Therapeutics, Inc. | 3.19M | 4.43% | 113,950 | - |
| 595 | SPRC | SciSparc Ltd. | 2.98M | -3.66% | 167,503 | 1.31M |
| 596 | VRAX | Virax Biolabs Group Limited | 2.97M | 2.37% | 315,102 | 2.99K |
| 597 | PBM | Psyence Biomedical Ltd. | 2.96M | 1.94% | 338,756 | - |
| 598 | BDRX | Biodexa Pharmaceuticals Plc | 2.94M | -24.60% | 456,659 | 104.90K |
| 599 | ELAB | PMGC Holdings Inc. | 2.86M | -6.33% | 66,875 | 285.95K |
| 600 | CDT | CDT Equity Inc. | 2.85M | -3.31% | 77,521 | - |
| 601 | DRMA | Dermata Therapeutics, Inc. | 2.70M | -4.36% | 55,338 | - |
| 602 | MLEC | Moolec Science SA | 1.75M | 0.14% | 19,962 | 7.83M |
| 603 | GRI | GRI Bio, Inc. | 1.73M | 0.21% | 1,516,749 | - |
| 604 | ADTX | Aditxt, Inc. | 1.25M | -5.49% | 207,107 | 5.95K |